Description

Global Veterinary Cancer Therapeutics Market Dynamics

 

The market for global veterinary cancer therapeutics is expected to gain traction owing to increase in adaptation of companion animals and growing meat consumption across the globe. Furthermore, increase in prevalence of cancer in animals especially in pets coupled with the increase in R&D investment by the companies to develop the cancer therapeutics such as preventive vaccines and chemotherapeutic agents projected to bolster the market share over the forecast period. In addition, rise in animal health expenditure and robust animal cancer pipeline expected to drive the market growth during the forecast period. However, lack of awareness about the animal cancer among the owners and high cost in development of the cancer therapeutics are expected to hamper the global veterinary cancer therapeutics market.

 

Global Market Scope

 

Based on product, global market is segmented into

  • Chemotherapeutic Agent
  • Vaccine
  • Others

 

Based on cancer, This market is segmented into

  • Mast Cell Tumors
  • Lymphoma
  • Insulinomas
  • Chondrosarcoma
  • Others

 

Based on Species, This market is segmented into

  • Bovine
  • Porcine
  • Cats
  • Dogs
  • Others

 

By region, This market is segmented into

  • North America
  • Latin America
  • Asia Pacific
  • Europe
  • Middle East and Africa (MEA)

 

Global Regional Analysis:

Geographically veterinary cancer therapeutics market is divided into five key regions, i.e. North America, Europe, AsiaPacific, Latin America, and the Middle East and Africa. North America veterinary cancer therapeutics market is expected to grow at significant rates owing to increase in prevalence of cancer in animals and presence of key market players with robust cancer pipeline drugs in the region. According to National cancer Institute, Each year 6 million cats and 6 million dogs are diagnosed with the spontaneous, naturally occurring cancer in United States alone. Europe veterinary cancer therapeutics market is expected to show notable growth rate owing to the growing animal health concerns and increase in R&D investments in development of animal cancer therapeutics. Asia Pacific veterinary cancer therapeutics market is expected to have the lucrative growth opportunity owing to the increase in adaptation of pets and increase in animal health expenditure.

 

Competition Assessment:

Some of the players in global veterinary cancer therapeutics market include

  • Merial (C.H. BoehringerSohn AG &Ko. KG) (Germany)
  • Zoetis Inc. (U.S.)
  • AB Science (France)
  • Aratana Therapeutics (U.S.)
  • Oasmia Pharmaceutical (Sweden)
  • Vetivax (U.S.)
  • Regeneus (Australia)

 

Notable Market Developments:

  • In October 2013, Aratana Therapeutics entered into a merger agreement to acquire Vet Therapeutics Inc. to advance its product pipeline.

 

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2015 to 2019) and forecast (2020 to 2026)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market


Location

GEOGRAPHY

PBI Location Map

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX